Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosis

By Miller Paul D  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2253-2258

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety

By Reffelmann Thorsten   Kloner Robert A  

Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. : 531-540

Informa Healthcare

Access to resources Recommend Favorite

Risedronate for prevention and treatment of osteoporosis in postmenopausal women

By Recker Robert R   Barger-Lux Janet  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 3, 2005-03 ,pp. : 465-477

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Management of Osteoporosis in Postmenopausal Women: A Comparative Review

By Reid I.R.  

Drugs & Aging, Vol. 15, Iss. 5, 1999-11 ,pp. : 349-363

Adis International

Access to resources Recommend Favorite

The Safety and Efficacy of Early-stage Bi-weekly Alendronate to Improve Bone Mineral Density and Bone Turnover in Chinese Post-menopausal Women at Risk of Osteoporosis

By You L   Sheng Z-Y   Chen J-Y   Pan L   Chen L  

The Journal of International Medical Research, Vol. 39, Iss. 1, 2011-01 ,pp. : 302-310

Field House Publishing

Access to resources Recommend Favorite